A sensitive HPLC method is reported for the Simultaneous determination of theophylline, caffeine, and phenobarbital in 100 of plasma.
n ro ucnon caffeine, reaching medically significant levels in Theophylline (1,,3-dimethylxanthine) and caffeine plasma (2, 3) . For this reason, it is important to (1,3,7-triinethylxanthine) are two drugs widely used determine both drugs simultaneously in order to esin the prevention and treatment of neonatal apnoea tablish an optimal individual dose and to prevent (1) . In neonates, theophylline is metabolized to toxicity.
Recently, several HPLC methods have been developed for the analysis of theophylline, caffeine, and other methylated xanthines (4 -6). However, no method has s yet been reported which permits the simultaneous determination of phenobarbital together with these drugs in a reasonable time period. Phenobarbital is, however, widely used s an enzyme inducer to prevent hyperbilirubinaemia in preterm neonates (7, 8) . In addition, it is used in the treatment of convulsions, and it is sometimes used in combination with theophylline in the treatment of apnoea. The half-life of this drug in neonates is relatively long with a wide interindividual variability (9 -11) . Thus, the simultaneous determination of phenobarbital would be very useful in order to avoid toxicity Symptoms of this drug in neonates.
We report here a gradient reversed-phase liquid Chromatographie method for a rapid, simultanqous determination of theophylline, caffeine, and phenobarbital in plasma. Plasma (100 μΐ) was extracted, using an efficient single-step method, which can also be adapted to 50 μΐ if necessary.
Materials and Methods
We used a Kontron HPLC System Model 620 (Z rich, Switzerland) coupled to a Uvikon variable wavelength ultraviolet spec- Stock Standards: these were prepared in methanol to give a concentration of 500 mg/1 for theophyiline, caffeine and 8-chlorotheophylline, and l g/l for phenobarbital.
Plasma Standards: these were prepared in df ug^free plasma in the r nge 0.5-40 mg/1 (theophylline, caffeine) and 5-80 mg/1 -(phenobarbital).
Internal Standard solution: this was prepared daily in water to
give a concentration of 10 mg/1.
Phosphate buffer: add 150 μΐ of l mol/1 KH 2 PO 4 to 1000 ml of water and adjust to pH 4.6 with 0.9 mol/1 H 3 PO 4 .
Mobile phase: solvent A -phosphate buffer; solvent Bacetonitrile. Before use, the organic solvent was filtered and degassed by passing i t through a 0.5 μπι Millipore filter type FHUPO4700 (Millipore Corp.) under reduced pressure. The buffer was passed under reduced pressure through a 0.45 μιη Millipore filter type HATF047EP. Quantification is based on the peak-height ratio of the analyte to the internal Standard.
Results

Chromatograms
Figure l shows typical chromatpgrams obtained with the reported procedure from extracts of a plasma blank and a plasma spiked with therape tic levels of the assayed drugs.
Linearity
We have investigated the linearity of the peak-height ratios versus plasma drug concentrations in the following ranges: 0. (3), and 20mg of phenobarbital (4). Peak (2) 
Precision
The precision of the method was determined by assaying plasma samples containing known quantities of the drugs. As shown in table l, within-day precision ranged from 1.2 to 6.2, and between-day precision ranged from 1.6 to 6.7%. 
Recovery
We determined the analytical recovery of the assayed drugs from plasma by cpmparing the peak-height Interferences Table 3 shows the retention time of the drugs tested for potential interference relative to the internal Standard. Of these drugs, only paraxanthine (1,7-dimethylxanthine), a metabolite of caffeine, co-elutes with theophylline. However, paraxanthine, which may exist in patients consuming coffee, is not present in the plasma of neonates (2, 12 
Discussion
We performed the extraction with a mixture of organic solvents in the presence of excess of ammonium sulphate. This procedure causes virtually complete precipitation of plasma proteins (13) , which otherwise would contaminate the column and the injection System (14) . The use of a low pH improves the analytical recovery of some drugs and allows the precipitation of some plasma lipid components. In the extraction we recommend vigorous vortex-mixing for a few seconds rather than continous vortexing, in order to avoid the formation of an emulsion. We used methanol to redissolve the dried extract because it does not affect the shape of peaks and, furthermore, increases the analytical recovery of theophylline.
We found it necessary to use a mobile-phase gradient because low concentrations of acetonitrile are essential for a good resolution of theophylline, caffeine, and some of their metabolites, while high concentrations of acetonitrile are necessary for a rapid elution of phenobarbital. 8-Chlorotheophylline was chosen äs internal Standard for its position in the chromatogram and for its good analytical recovery. Phosphate buffer pH 4.6 was föürid to play an important role in obtaining a good resolution between caffeine and the internal Standard. The column efflüent was monitored at 204 nm because this wäve-length provides adequate sensivity for all the assayed drugs.
To prevent büild-üp of any strongly retained mat·ê rials on the HPLC column, the Chromatographie System was purged at the end of each workday with water for 15 min followed by acetonitrile for othef 15 min, at a flow rate of 3 ml/min. The method äs repörted here uses 100 of plasma, but its high sensitivity permits adaptatiori to 50 if desirable.
